"99% purity" is the most common claim in the research peptide market and answers only one of three distinct questions. Purity, identity, and potency require different analytical methods, and a product can satisfy one specification completely while failing another.
Research peptide suppliers that publish complete documentation, including Pen Peptide USA, address these specifications independently rather than presenting a single figure as a general quality statement.
Purity describes what proportion of the material is a single chemical species. It is measured by reversed-phase high-performance liquid chromatography with UV detection.
A high purity figure establishes that synthesis and purification removed most truncated sequences, deletion products, and reagent residues. This is meaningful, because solid-phase peptide synthesis is stepwise and each failed coupling cycle leaves a shorter chain behind. Crude synthesis product is frequently below 70% target.
Purity establishes nothing about which molecule the main peak represents. A sample can be 99.5% pure and entirely the wrong peptide. Purity is a statement about homogeneity, not correctness.
Identity is confirmed by mass spectrometry, typically ESI-MS or MALDI-TOF, which reports observed molecular weight against the theoretical mass of the intended sequence.
Agreement excludes gross substitution — a different compound, or a chain missing residues. It does not exclude:
Full sequence confirmation requires MS/MS fragmentation or amino acid analysis. Most commercial certificates include neither, which means the identity assurance provided is partial.
Synthetic peptides are isolated as salts. Basic residues carry counterions — trifluoroacetate from HPLC purification, or acetate after ion exchange. Lyophilized powder is hygroscopic and retains bound water. All of that contributes mass alongside the peptide.
The arithmetic is unforgiving. A container labelled 10 mg, at 98% HPLC purity and 78% net peptide content, holds approximately 7.6 mg of target peptide. Calculating concentration from the label alone overstates it by roughly 30%.
This error is systematic. It does not average out across replicates and will not appear as noise. It shifts every result in the same direction while internal consistency appears excellent. Net peptide content is determined by amino acid analysis or nitrogen determination.
Consider three plausible products:
The second product is the strongest of the three and advertises the worst. This is why headline purity dominates marketing while net peptide content is rarely displayed prominently.
For products supplied as dry powder, the end user derives working concentration from label weight, purity, and net peptide content. For pre-mixed formats, concentration in the delivered solution is itself the product specification, set and verified by the supplier.
Pen Peptide USA supplies research peptides in pre-filled pen devices, a format in which concentration is defined at manufacture rather than calculated at the bench. Suppliers using this format should be able to state the concentration of the delivered solution and the method by which it was verified.
Purity is measured by chromatography, identity by mass spectrometry, and potency by net peptide content. Each requires a different method and none substitutes for another. A single purity percentage is an incomplete specification, and buyers evaluating research peptide suppliers should require all three independently.
For laboratory and research audiences. Research peptides are supplied for laboratory research use only and are not intended for human or veterinary use. Nothing here constitutes medical or regulatory advice.